MigraineMind research summary

Photobiomodulation and Migraine: Mechanisms and Therapeutic Potential.

Photobiomodul Photomed Laser Surg | 2026

Laboratory / animal study
AuthorsMachado LDS, Schwartz AY, Lizarelli RFZ, Salgado ASI, Lopes-Martins RÁB
JournalPhotobiomodul Photomed Laser Surg
Publication year2026
PubMed ID42751720

Summary

Migraine is a common and debilitating condition affecting many people worldwide. It involves issues like mitochondrial dysfunction and neuroinflammation. Researchers are exploring photobiomodulation, a noninvasive treatment using red or near-infrared light. This therapy shows promise for improving migraine symptoms. It works by enhancing mitochondrial function and increasing energy production in cells. Photobiomodulation also helps balance important molecules in the body. This process improves blood flow to the brain and reduces inflammation. Studies suggest that using this light therapy may help alleviate migraine attacks. The review analyzed various studies to understand how this treatment works. Overall, the findings indicate that photobiomodulation could be a valuable option for migraine sufferers. More research is needed to confirm its effectiveness and optimize treatment protocols. Nonetheless, this approach offers hope for those seeking relief from chronic migraine pain. Clinical relevance: This research highlights photobiomodulation as a potential new treatment for migraine, offering hope for better management and relief for patients.

Original research

Read the original publication and review its full methods and findings on PubMed.

MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.